Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
440.00    0.00 (0.00%)
Bid:
330.00
Ask:
505.00
Spread: 175.00 (53.03%)
Market Cap: £11.07b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Further re Joint Venture with Haniel

8 Jun 2017 11:40

RNS Number : 5563H
Rentokil Initial PLC
08 June 2017
 

8 June 2017

 

European Commission Unconditional Clearance: Rentokil Initial Joint Venture with Haniel

Rentokil Initial plc (FTSE: RTO, "the Company") and Franz Haniel & Cie. GmbH ("Haniel") announced on 16 December 2016 that they had entered into an agreement to form a joint venture, creating a leading provider of Workwear and Hygiene services in Europe, and that completion of the transaction would be conditional on receipt of competition clearance from the European Commission. 

The European Commission has today cleared the formation of the joint venture under the EC Merger Regulation unconditionally. There are no further conditions to completion of the transaction.

Having also now completed all necessary employee information and consultation procedures, including receiving 'positive advice' from the Netherlands Works Council, the transaction is expected to complete on or around 30 June 2017.

ENDS

Notes to editors:

Rentokil Initial

Rentokil Initial is one of the largest business services companies in the world, operating in over 65 countries and employing 38,000 colleagues. The Company offers route-based services including Pest Control, Hygiene and Workwear through teams of local experts. For more information, visit www.rentokil-initial.com.

Joint Venture: Background

The joint venture brings together Rentokil Initial's Workwear and Hygiene businesses in 10 countries principally in the Benelux and Central & Eastern Europe regions, together with Haniel's businesses in 17 countries which operate under the CWS-boco brand. The JV will have revenues of c. €1.1bn and APBITA of c. €130m (12 months to 30 June 2016).

Enquiries:

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

 

Ben Woodford/Sam Cartwright

Bell Pottinger

0203 772 2588

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURBGGDLLXGBGRI
Date   Source Headline
3rd Oct 20222:36 pmRNSBlock listing Interim Review
30th Sep 202211:42 amRNSDirector Declaration
14th Sep 20225:55 pmRNSDirector/PDMR Shareholding
14th Sep 202212:21 pmRNSDirector/PDMR Shareholding
7th Sep 20222:38 pmRNSPublication of Circular-Prospectus & GM Notice
22nd Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20222:02 pmRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNS2022 Interim Results
27th Jul 20229:54 amRNSDirector Declaration
18th Jul 20223:11 pmRNSHolding(s) in Company
15th Jul 20225:30 pmRNSHolding(s) in Company
15th Jul 202211:57 amRNSHolding(s) in Company
27th Jun 20222:27 pmRNSPost stabilisation notice - Rentokil Initial Plc
22nd Jun 20224:16 pmRNSHolding(s) in Company
21st Jun 20223:37 pmRNSDirector/PDMR Shareholding
20th Jun 20229:12 amRNSPre stabilisation notice - Rentokil Initial Plc
20th May 202210:20 amRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSResult of AGM
21st Apr 20227:00 amRNSQ1 Trading Update
1st Apr 20227:00 amRNSBlock listing Interim Review
31st Mar 20226:15 pmRNSTotal Voting Rights
30th Mar 20229:44 amRNSAnnual Financial Report
29th Mar 20222:20 pmRNSDirector/PDMR Shareholding
25th Mar 20224:31 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSUpdate on Terminix acquisition
14th Mar 202211:00 amRNSAdditional Listing
3rd Mar 20227:00 amRNSFinal Results
2nd Mar 202210:29 amRNSDirector/PDMR Shareholding
28th Feb 20224:47 pmRNSHolding(s) in Company
22nd Dec 20215:38 pmRNSDirector/PDMR Shareholding
21st Dec 20214:09 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFurther re Terminix Acqn S&P reaffirms BBB rating
15th Dec 20212:02 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition of Terminix by Rentokil Initial plc
22nd Oct 202110:42 amRNSDirector Declaration
21st Oct 20217:00 amRNSQ3 Trading Update
1st Oct 202110:00 amRNSBlock listing Interim Review
28th Sep 20217:00 amRNSNotice of Capital Markets Day
17th Aug 20216:09 pmRNSDirector/PDMR Shareholding
12th Aug 20214:48 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSInterim Results
8th Jul 20217:00 amRNSNotice of termination of guarantee
11th Jun 20211:50 pmRNSNotice of Early Redemption
12th May 20216:03 pmRNSResult of AGM
22nd Apr 20217:00 amRNSQ1 Trading Update
7th Apr 20212:01 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
1st Apr 202110:23 amRNSBlock listing Interim Review
1st Apr 202110:16 amRNSChange of Registered Office
31st Mar 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.